Abstract：Objective To explore the changes of plasma nonenzyme antioxidants and levels of thyroid hormone and their clinical significance in patients with unipolar and bipolar depression. Methods One hundred and one patients with unipolar depression (unipolar depression group), 103 patients with bipolar depression (bipolar depression group) and 85 healthy controls (control group) were enrolled in the Renmin Hospital of Wuhan University from February 2016 to December 2016. According to the questionnaire and Hamilton depression scale, patients of the unipolar depression group and bipolar depression group were divided into negative and non-negative groups respectively. Serum levels of uric acid, albumin, total bilirubin, free triiodothyronine (FT3), free thyroxine (FT4) and hemosiderin (TSH) of each group were measured and compared. Results The levels of uric acid in the bipolar depression group were significantly higher than that in the unipolar depression and control group, the level of uric acid in the unipolar depression group was lower than that of the control group, the levels of albumin and total bilirubin in the unipolar depression group and bipolar depression group were significantly lower than control group, and the both unipolar and bipolar depression group. The level of FT3 in the unipolar depression group was significantly lower than that in the bipolar depression group and the control group, there was no statistically significant difference in FT4, TSH among the three groups (P > 0.05). The level of FT3 in the non-negative groups was significantly lower than that in the negative group, the difference was statistically significant (P < 0.05). Conclusion Serum uric acid, albumin, total bilirubin and thyroid hormone levels are altered in patients with unipolar and bipolar depression, and the level of serum uric acid can be used as an auxiliary reference index for the differential diagnosis between unipolar and bipolar depression.
付林燕 刘忠纯▲ 相丹 肖佳维. 单、双相抑郁患者血浆非酶类抗氧化物和甲状腺激素水平研究[J]. 中国医药导报, 2018, 15(8): 100-103.
FU Linyan LIU Zhongchun▲ XIANG Dan XIAO Jiawei. Study of plasma non-enzyme antioxidants and thyroid hormone levels in patients with unipolar and bipolar depression. 中国医药导报, 2018, 15(8): 100-103.
[1] Sarandol A，Sarandol E，Acikgoz HE，et al. First‐episode psychosis is associated with oxidative stress：Effects of short—term antipsychotic treatment [J]. Psychiatry & Clinical Neurosciences，2015，69（11）：699-707.
[2] Steenkamp LR，Hough CM，Reus VI，et al. Severity of anxiety- but not depression- is associated with oxidative stress in Major Depressive Disorder [J]. J Affect Disord，2017，219（9）：193-200.
[3] Liu T，Zhong S，Liao X，et al. A Meta-Analysis of Oxidative Stress Markers in Depression [J]. PLoS One，2015，10（10）：e0138904.
[4] Meyer JH. Neuroprogression and Immune Activation in Major Depressive Disorder [J]. Modern Trends in Pharmacopsychiatry，2017，31（7）：27-36.
[5] Joshi YB，Praticò D. Lipid peroxidation in psychiatric illness：overview of clinical evidence [J]. Oxidative Medicine & Cellular Longevity，2014，2014（2）：289-303.
[6] de Sousa RT，Zarate CA Jr，Zanetti MV，et al. Oxidative stress in early stage Bipolar Disorder and the association with response to lithium [J]. J Psychiatr Res，2014，50（1）：36-41.
[7] Lindberg D，Shan D，Ayersringler J，et al. Purinergic Signaling and Energy Homeostasis in Psychiatric Disorders [J]. Cur Mol Med，2015，15（3）：275-295.
[8] Krügel U.Purinergic receptors in psychiatric disorders [J]. Neuropharmacology，2016，104（5）：212-225.
[9] Ortiz R，Ulrich H，Jr ZC，et al. Purinergic system dysfunction in mood disorders：a key target for developing improved therapeutics [J]. Prog Neuropsychopharmacol Biol Psychiatry，2015，57（3）：117-131.
[10] Jahangard L，Soroush S，Haghighi M，et al. In a double-blind，randomized and placebo-controlled trial，adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder [J]. Eur Neuropsychopharmacol，2014，24（8）：1210-1221.
[11] 陈红梅，田成华，陈景旭，等.双相障碍躁狂发作治疗前后血清尿酸水平分析[J].国际精神病学杂志，2016，43（2）：239-242.
[12] Sutin AR，Cutler RG，Camandola S，et al. Impulsivity is Associated with Uric Acid：Evidence from Humans and Mice [J]. Biological Psychiatry，2014，75（1）：31-37.
[13] Gubert C，Jacintho Moritz CE，Vasconcelos-Moreno MP，et al. Peripheral adenosine levels in euthymic patients with bipolar disorder [J]. Psychiatry Research，2016，246（12）：421-426.
[14] Kesebir S，Tatlidil YE，Süner O，et al.Uric acid levels may be a biological marker for the differentiation of unipolar and bipolar disorder：the role of affective temperament [J]. J Affect Disord，2014，165（8）：131-134.
[15] Bowman GL，Shannon J，Frei B，et al. Uric Acid as a CNS Antioxidant [J]. JAD，2010，19（4）：1331-1336.
[16] Zhou X，Ravindran AV，Qin B，et al. Comparative efficacy，acceptability，and tolerability of augmentation agents in treatment-resistant depression：systematic review and network meta-analysis [J]. J Clin Psychiatry，2015，76（4）：e487-e498.
[17] Ittermann T，V?觟lzke H，Baumeister SE，et al. Diagnosed thyroid disorders are associated with depression and anxiety [J]. Social Psychiatry & Psychiatric Epidemiology，2015，50（9）：1417-1425.
[18] Medici M，Direk N，Visser WE，et al. Thyroid function within the normal range and the risk of depression：a population-based cohort study [J]. J Clin Endocrinol Metab，2014， 99（4）：1213-1219.
[20] Shim IH，Woo YS，Bae DS，et al. Thyroid functioning in patients with bipolar disorder with mixed features [J]. Psychiatry Research，2015，225（1–2）：212-214.
[21] Duval F，Mokrani MC，Erb A，et al. Relationship between chronobiological thyrotropin and prolactin responses to protirelin（TRH）and suicidal behavior in depressed patients [J]. Psychoneuroendocrinology，2017，85（7）：100-109.
2018, Vol. 15 
京公网安备 11010502046598号